Novo Nordisk CEO to step down as Wegovy maker faces growing competition
The Danish pharmaceutical giant said Fruergaard Jørgensen would remain in his post "for a period to support a smooth transition to new leadership."
You are not logged in so some information on this page has been withheld. To see more, please log in.
Fruergaard Jørgensen
since
auto-detected in 27 stories
19 days ago
3 months ago
Denmark wanted advice on handling Trump. It turned to Ozempic’s boss.
found
a story from Politico EU ✅ › Politico EU
Lars Fruergaard Jørgensen might not be a household name, but his company’s drug Ozempic is. And its success has thrust him — reluctantly — into the limelight.
page 1 of 1